3
Shared Docs
3
Same-Page
3 / 3
Mentions
arning/science sessions in Europe with some of the Israeli companies Academic Highlights Immune Gatekeeping in Aging and Degenerative Disease Dr. Michael Schwartz Lab: http://www.weizmann.ac.il/neurobiology/labs/schwartz/ Can immunotherapy treat neurodegeneration? Dr. Schwartz has a notable research background
are specifically going after discovering novel antibodies in partnership with Lundbeck. Cellular Rejuvenation Therapy and Biomarker Development Dr. Shai Efrati Lab: http://www.assafh.org/sites/en/clinic/Hifrbaric/Pages/default.aspx Hyperbaric medicine was originally conceptualized to ameliorate the effects o
sity of California, San Francisco=/span> =font face="verdana, sans-serif">• Weizmann Institu=e Immunological gating pathways and denegeration: Dr. Michael Schwartz / =font face="verdana, sans-serif">• Rejuvenation of the nervous and vascular systems: Dr. Shai Efrati / Sagol Center Filamentous bacteriophages a
l gating pathways and denegeration: Dr. Michael Schwartz / =font face="verdana, sans-serif">• Rejuvenation of the nervous and vascular systems: Dr. Shai Efrati / Sagol Center Filamentous bacteriophages as therapeutics: Proclara biosciences (may be better fit f=r DDF) <=pan> <=ont face="verdana, sans-serir
Ley (La Jolla Institute for Immunology) - Vaccines for things beyond infectious disease 12. Charles Gersbach (Duke) - Programming the epigenome 13. Michael Schwartz (Weizmann) - Neuroimmuno gatekeeping 14. Eran Elinav (Weizmann) - Personalized nutrition / microbiome 15. Shai Efrati (Tel Aviv U) — hyperbarics 1
mming the epigenome 13. Michael Schwartz (Weizmann) - Neuroimmuno gatekeeping 14. Eran Elinav (Weizmann) - Personalized nutrition / microbiome 15. Shai Efrati (Tel Aviv U) — hyperbarics 16. Neal Kassell (FUS Foundation) — focused ultrasound 17. James McCully (Boston Children's Hospital/Harvard) — mitochon
Entities connected to both Michael Schwartz and Shai Efrati